Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care.
Alcohol use disorder
HIV
Unhealthy alcohol use
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
accepted:
20
09
2022
pmc-release:
01
05
2024
medline:
17
5
2023
pubmed:
29
9
2022
entrez:
28
9
2022
Statut:
ppublish
Résumé
Outcomes of PWH with unhealthy alcohol use, such as alcohol use reduction or progression to AUD, are not well-known and may differ by baseline patterns of unhealthy alcohol use. Among 1299 PWH screening positive for NIAAA-defined unhealthy alcohol use in Kaiser Permanente Northern California, 2013-2017, we compared 2-year probabilities of reduction to low-risk/no alcohol use and rates of new AUD diagnoses by baseline use patterns, categorized as exceeding: only daily limits (72% of included PWH), only weekly limits (17%), or both (11%), based on NIAAA recommendations. Overall, 73.2% (95% CI 70.5-75.9%) of re-screened PWH reduced to low-risk/no alcohol use over 2 years, and there were 3.1 (95% CI 2.5-3.8%) new AUD diagnoses per 100 person-years. Compared with PWH only exceeding daily limits at baseline, those only exceeding weekly limits and those exceeding both limits were less likely to reduce and likelier to be diagnosed with AUD during follow-up. PWH exceeding weekly drinking limits, with or without exceeding daily limits, may have a potential need for targeted interventions to address unhealthy alcohol use.
Identifiants
pubmed: 36169779
doi: 10.1007/s10461-022-03873-5
pii: 10.1007/s10461-022-03873-5
pmc: PMC10043049
mid: NIHMS1839879
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1380-1391Subventions
Organisme : NIAAA NIH HHS
ID : K24AA025703
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026230
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01AA026230
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA025902
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24 AA025703
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007250
Pays : United States
Organisme : NIDA NIH HHS
ID : T32DA007250
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01 AA025902
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24AA025703
Pays : United States
Organisme : NIAAA NIH HHS
ID : R01AA025902
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01AA026230
Pays : United States
Organisme : NIDA NIH HHS
ID : T32DA007250
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Crane HM, Nance RM, Whitney BM, Ruderman S, Tsui JI, Chander G, et al. Drug and alcohol use among people living with HIV in care in the United States by geographic region. AIDS Care. 2021;33(12):1569–76.
doi: 10.1080/09540121.2021.1874274
pubmed: 33486978
pmcid: 9104760
Centers for Disease Control and Prevention. Behavioral and clinical characteristics of persons with diagnosed HIV infection—medical monitoring project, United States, 2019 cycle (June 2019–May 2020): HIV surveillance special report 28; 2021. Available from: https://www.cdc.gov/hiv/library/reports/hiv-surveillance-special-reports/no-28/index.html .
Park LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016;30(2):273–91.
doi: 10.1097/QAD.0000000000000922
pubmed: 26691548
Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352(6):596–607.
doi: 10.1056/NEJMcp042262
pubmed: 15703424
Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006;43(4):411–7.
doi: 10.1097/01.qai.0000243121.44659.a4
pubmed: 17099312
pmcid: 2704473
Monroe AK, Lau B, Mugavero MJ, Mathews WC, Mayer KH, Napravnik S, et al. Heavy alcohol use is associated with worse retention in HIV care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.
doi: 10.1097/QAI.0000000000001083
pubmed: 27243904
pmcid: 5085857
Lesko CR, Keil AP, Fojo AT, Chander G, Lau B, Moore RD. Recent substance use and probability of unsuppressed HIV viral load among persons on antiretroviral therapy in continuity care. Am J Epidemiol. 2019;188(10):1830–7.
doi: 10.1093/aje/kwz159
pubmed: 31360995
pmcid: 6768806
Klein MB, Althoff KN, Jing Y, Lau B, Kitahata M, Lo Re V 3rd, et al. Risk of end-stage liver disease in HIV-viral hepatitis coinfected persons in North America from the early to modern antiretroviral therapy eras. Clin Infect Dis. 2016;63(9):1160–7.
pubmed: 27506682
pmcid: 5064164
Freiberg MS, McGinnis KA, Kraemer K, Samet JH, Conigliaro J, Curtis Ellison R, et al. The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men. J Acquir Immune Defic Syndr. 2010;53(2):247–53.
doi: 10.1097/QAI.0b013e3181c6c4b7
pubmed: 20009766
pmcid: 2858978
Rothlind JC, Greenfield TM, Bruce AV, Meyerhoff DJ, Flenniken DL, Lindgren JA, et al. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc. 2005;11(1):70–83.
doi: 10.1017/S1355617705050095
pubmed: 15686610
pmcid: 2376753
Rentsch C, Tate JP, Akgun KM, Crystal S, Wang KH, Ryan Greysen S, et al. Alcohol-related diagnoses and all-cause hospitalization among HIV-infected and uninfected patients: a longitudinal analysis of United States veterans from 1997 to 2011. AIDS Behav. 2016;20(3):555–64.
doi: 10.1007/s10461-015-1025-y
pubmed: 25711299
pmcid: 4550577
Jolley SE, Alkhafaf Q, Hough C, Welsh DA. Presence of an alcohol use disorder is associated with greater pneumonia severity in hospitalized HIV-infected patients. Lung. 2016;194(5):755–62.
doi: 10.1007/s00408-016-9920-1
pubmed: 27405853
pmcid: 5786386
Wada N, Jacobson LP, Cohen M, French A, Phair J, Munoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984–2008. Am J Epidemiol. 2013;177(2):116–25.
doi: 10.1093/aje/kws321
pubmed: 23287403
pmcid: 3590031
Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, et al. Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care. J Acquir Immune Defic Syndr. 2016;73(1):39–46.
doi: 10.1097/QAI.0000000000001014
pubmed: 27028501
pmcid: 5427712
DeLorenze GN, Weisner C, Tsai AL, Satre DD, Quesenberry CP Jr. Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res. 2011;35(2):203–10.
doi: 10.1111/j.1530-0277.2010.01335.x
pubmed: 21058961
Althoff KN, Chandran A, Zhang J, Arevalo WM, Gange SJ, Sterling TR, et al. Life-expectancy disparities among adults with HIV in the United States and Canada: the impact of a reduction in drug- and alcohol-related deaths using the lives saved simulation model. Am J Epidemiol. 2019;188(12):2097–109.
doi: 10.1093/aje/kwz232
pubmed: 31602475
pmcid: 7036649
Justice AC, McGinnis KA, Tate JP, Braithwaite RS, Bryant KJ, Cook RL, et al. Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. Drug Alcohol Depend. 2016;161:95–103.
doi: 10.1016/j.drugalcdep.2016.01.017
pubmed: 26861883
pmcid: 4792710
Thompson MA, Horberg MA, Agwu AL, Colasanti JA, Jain MK, Short WR, et al. Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2021;73(11):e3572–605.
doi: 10.1093/cid/ciaa1391
pubmed: 33225349
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services; 2021. Available from: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf .
U. S. Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(18):1899–909.
doi: 10.1001/jama.2018.16789
Crane HM, McCaul ME, Chander G, Hutton H, Nance RM, Delaney JAC, et al. Prevalence and factors associated with hazardous alcohol use among persons living with HIV across the US in the current era of antiretroviral treatment. AIDS Behav. 2017;21(7):1914–25.
doi: 10.1007/s10461-017-1740-7
pubmed: 28285434
pmcid: 5628735
Silverberg MJ, Leyden WA, Leibowitz A, Hare CB, Jang HJ, Sterling S, et al. Factors associated with hazardous alcohol use and motivation to reduce drinking among HIV primary care patients: baseline findings from the Health & Motivation study. Addict Behav. 2018;84:110–7.
doi: 10.1016/j.addbeh.2018.03.033
pubmed: 29660593
pmcid: 5975127
Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Christopher Mathews W, et al. Prevalence and predictors of substance use disorders among HIV care enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.
doi: 10.1007/s10461-016-1584-6
pubmed: 27738780
pmcid: 6089366
Cook RL, Zhu F, Belnap BH, Weber KM, Cole SR, Vlahov D, et al. Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav. 2013;17(5):1705–12.
doi: 10.1007/s10461-012-0270-6
pubmed: 22836592
pmcid: 3534826
Bilal U, McCaul ME, Crane HM, Mathews WC, Mayer KH, Geng E, et al. Predictors of longitudinal trajectories of alcohol consumption in people with HIV. Alcohol Clin Exp Res. 2018;42(3):561–70.
doi: 10.1111/acer.13583
pubmed: 29265385
pmcid: 5832592
Marshall BD, Shoveller JA, Kahler CW, Koblin BA, Mayer KH, Mimiaga MJ, et al. Heavy drinking trajectories among men who have sex with men: a longitudinal, group-based analysis. Alcohol Clin Exp Res. 2015;39(2):380–9.
doi: 10.1111/acer.12631
pubmed: 25684055
pmcid: 4331451
Marshall BDL, Tate JP, McGinnis KA, Bryant KJ, Cook RL, Edelman EJ, et al. Long-term alcohol use patterns and HIV disease severity. AIDS. 2017;31(9):1313–21.
doi: 10.1097/QAD.0000000000001473
pubmed: 28492393
Kelso-Chichetto NE, Plankey M, Abraham AG, Ennis N, Chen X, Bolan R, et al. Association between alcohol consumption trajectories and clinical profiles among women and men living with HIV. Am J Drug Alcohol Abuse. 2018;44(1):85–94.
doi: 10.1080/00952990.2017.1335317
pubmed: 28621562
Williams EC, McGinnis KA, Tate JP, Matson TE, Rubinsky AD, Bobb JF, et al. HIV disease severity is sensitive to temporal changes in alcohol use: a national study of VA patients with HIV. J Acquir Immune Defic Syndr. 2019;81(4):448–55.
doi: 10.1097/QAI.0000000000002049
pubmed: 30973541
pmcid: 6594884
Williams EC, McGinnis KA, Rubinsky AD, Matson TE, Bobb JF, Lapham GT, et al. Alcohol use and antiretroviral adherence among patients living with HIV: is change in alcohol use associated with change in adherence? AIDS Behav. 2021;25(1):203–14.
doi: 10.1007/s10461-020-02950-x
pubmed: 32617778
pmcid: 7775874
Satre DD, Sarovar V, Leyden W, Hare CB, Catz SL, Bryant KJ, et al. Changes in days of unhealthy alcohol use and antiretroviral therapy adherence, HIV RNA levels, and condomless sex: a secondary analysis of clinical trial data. AIDS Behav. 2020;24(6):1784–92.
doi: 10.1007/s10461-019-02742-y
pubmed: 31773444
pmcid: 7406176
Lesko CR, Nance RM, Lau B, Fojo AT, Hutton HE, Delaney JAC, et al. Changing patterns of alcohol use and probability of unsuppressed viral load among treated patients with HIV engaged in routine care in the United States. AIDS Behav. 2021;25(4):1072–82.
doi: 10.1007/s10461-020-03065-z
pubmed: 33064249
Cook RL, Zhou Z, Miguez MJ, Quiros C, Espinoza L, Lewis JE, et al. Reduction in drinking was associated with improved clinical outcomes in women with HIV infection and unhealthy alcohol use: results from a randomized clinical trial of oral naltrexone versus placebo. Alcohol Clin Exp Res. 2019;43(8):1790–800.
doi: 10.1111/acer.14130
pubmed: 31373701
pmcid: 6684328
Satre DD, Leibowitz AS, Leyden W, Catz SL, Hare CB, Jang H, et al. Interventions to reduce unhealthy alcohol use among primary care patients with HIV: the health and motivation randomized clinical trial. J Gen Intern Med. 2019;34(10):2054–61.
doi: 10.1007/s11606-019-05065-9
pubmed: 31187344
pmcid: 6816606
Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, et al. Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial. Addict Sci Clin Pract. 2020;15(1):28.
doi: 10.1186/s13722-020-00200-y
pubmed: 32727618
pmcid: 7388231
Chander G, Hutton HE, Lau B, Xu X, McCaul ME. Brief intervention decreases drinking frequency in HIV-infected, heavy drinking women: results of a randomized controlled trial. J Acquir Immune Defic Syndr. 2015;70(2):137–45.
doi: 10.1097/QAI.0000000000000679
pubmed: 25967270
pmcid: 4634011
Naar S, Robles G, MacDonell KK, Dinaj-Koci V, Simpson KN, Lam P, et al. Comparative effectiveness of community-based vs clinic-based healthy choices motivational intervention to improve health behaviors among youth living With HIV: a randomized clinical trial. JAMA Netw Open. 2020;3(8): e2014650.
doi: 10.1001/jamanetworkopen.2020.14650
pubmed: 32845328
pmcid: 7450347
Edelman EJ, Moore BA, Holt SR, Hansen N, Kyriakides TC, Virata M, et al. Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: a randomized-controlled trial. AIDS Behav. 2019;23(1):211–21.
doi: 10.1007/s10461-018-2241-z
pubmed: 30073637
pmcid: 6476298
Edelman EJ, Maisto SA, Hansen NB, Cutter CJ, Dziura J, Deng Y, et al. Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial. Lancet HIV. 2019;6(8):e509–17.
doi: 10.1016/S2352-3018(19)30076-1
pubmed: 31109915
pmcid: 7161741
Williams EC, Lapham GT, Bobb JF, Rubinsky AD, Catz SL, Shortreed SM, et al. Documented brief intervention not associated with resolution of unhealthy alcohol use one year later among VA patients living with HIV. J Subst Abuse Treat. 2017;78:8–14.
doi: 10.1016/j.jsat.2017.04.006
pubmed: 28554608
pmcid: 5674978
McCaul ME, Hutton HE, Cropsey KL, Crane HM, Lesko CR, Chander G, et al. Decreased alcohol consumption in an implementation study of computerized brief intervention among HIV patients in clinical care. AIDS Behav. 2021;25(12):4074–84.
doi: 10.1007/s10461-021-03295-9
pubmed: 33993353
pmcid: 8594281
Cook RL, Zhou Z, Kelso-Chichetto NE, Janelle J, Morano JP, Somboonwit C, et al. Alcohol consumption patterns and HIV viral suppression among persons receiving HIV care in Florida: an observational study. Addict Sci Clin Pract. 2017;12(1):22.
doi: 10.1186/s13722-017-0090-0
pubmed: 28950912
pmcid: 5615807
Surial B, Bertholet N, Daeppen JB, Darling KEA, Calmy A, Gunthard HF, et al. The impact of binge drinking on mortality and liver disease in the Swiss HIV Cohort Study. J Clin Med. 2021;10(2):295.
doi: 10.3390/jcm10020295
pubmed: 33466907
pmcid: 7830571
Elliott JC, Aharonovich E, O’Leary A, Wainberg M, Hasin DS. Drinking motives among HIV primary care patients. AIDS Behav. 2014;18(7):1315–23.
doi: 10.1007/s10461-013-0644-4
pubmed: 24165984
pmcid: 4004709
Kaner EF, Beyer FR, Muirhead C, Campbell F, Pienaar ED, Bertholet N, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2018;2(2):CD004148.
pubmed: 29476653
Andersen R, Newman JF. Societal and individual determinants of medical care utilization in the United States. Milbank Mem Fund Q Health Soc. 1973;51(1):95–124.
doi: 10.2307/3349613
pubmed: 4198894
Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302.
pubmed: 10654830
pmcid: 1089079
Babitsch B, Gohl D, von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998–2011. Psychosoc Med. 2012;9:Doc11.
pubmed: 23133505
pmcid: 3488807
Atukunda EC, Matthews LT, Musiimenta A, Agaba A, Najjuma JN, Lukyamuzi EJ, et al. Understanding the effect of a healthcare provider-led family planning support intervention on contraception use and pregnancy desires among postpartum women living with HIV in Southwestern Uganda. AIDS Behav. 2022;26(1):266–76.
doi: 10.1007/s10461-021-03380-z
pubmed: 34292430
Chapman Lambert C, Marrazzo J, Amico KR, Mugavero MJ, Elopre L. PrEParing women to prevent HIV: an integrated theoretical framework to PrEP Black women in the United States. J Assoc Nurses AIDS Care. 2018;29(6):835–48.
doi: 10.1016/j.jana.2018.03.005
pubmed: 29685648
Dombrowski JC, Galagan SR, Ramchandani M, Dhanireddy S, Harrington RD, Moore A, et al. HIV care for patients with complex needs: a controlled evaluation of a walk-in, incentivized care model. Open Forum Infect Dis. 2019;6(7):ofz294.
doi: 10.1093/ofid/ofz294
pubmed: 31341930
pmcid: 6641789
Wachira J, Genberg B, Mwangi A, Chemutai D, Braitstein P, Galarraga O, et al. Impact of an enhanced patient care intervention on viral suppression among patients living with HIV in Kenya. J Acquir Immune Defic Syndr. 2022;90(4):434–9.
doi: 10.1097/QAI.0000000000002987
pubmed: 35320121
Holtzman CW, Shea JA, Glanz K, Jacobs LM, Gross R, Hines J, et al. Mapping patient-identified barriers and facilitators to retention in HIV care and antiretroviral therapy adherence to Andersen’s Behavioral Model. AIDS Care. 2015;27(7):817–28.
doi: 10.1080/09540121.2015.1009362
pubmed: 25671515
pmcid: 4400221
Satre DD, DeLorenze GN, Quesenberry CP, Tsai A, Weisner C. Factors associated with treatment initiation for psychiatric and substance use disorders among persons with HIV. Psychiatr Serv. 2013;64(8):745–53.
doi: 10.1176/appi.ps.201200064
pubmed: 23584606
pmcid: 4030718
Satre DD, Knight BG, Dickson-Fuhrmann E, Jarvik LF. Predictors of alcohol-treatment seeking in a sample of older veterans in the GET SMART program. J Am Geriatr Soc. 2003;51(3):380–6.
doi: 10.1046/j.1532-5415.2003.51112.x
pubmed: 12588582
Gordon N, Lin T. The Kaiser Permanente Northern California adult member health survey. Perm J. 2016;20(4):15–225.
doi: 10.7812/TPP/15-225
pubmed: 27548806
pmcid: 5101088
Gordon NP. Similarity of Adult Kaiser Permanente Members to the adult population in Kaiser Permanente’s Northern California service area: comparisons based on the 2017/2018 cycle of the California Health Interview Survey. Oakland: Kaiser Permanente Division of Research; 2020. Available from: https://divisionofresearch.kaiserpermanente.org/projects/memberhealthsurvey/SiteCollectionDocuments/compare_kp_ncal_chis2017-18.pdf .
Mertens JR, Chi FW, Weisner CM, Satre DD, Ross TB, Allen S, et al. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract. 2015;10:26.
doi: 10.1186/s13722-015-0047-0
pubmed: 26585638
pmcid: 4653951
National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician's guide, updated 2005 edition. US Department of Health and Human Services; 2016. Available from: https://pubs.niaaa.nih.gov/publications/practitioner/cliniciansguide2005/guide.pdf .
Palzes VA, Kline-Simon AH, Satre DD, Sterling S, Weisner C, Chi FW. Remission from unhealthy drinking among patients with an alcohol use disorder: a longitudinal study using systematic, primary care-based alcohol screening data. J Stud Alcohol Drugs. 2020;81(4):436–45.
doi: 10.15288/jsad.2020.81.436
pubmed: 32800079
pmcid: 7437559
Dawson DA. Alcohol consumption, alcohol dependence, and all-cause mortality. Alcohol Clin Exp Res. 2000;24(1):72–81.
doi: 10.1111/j.1530-0277.2000.tb04556.x
pubmed: 10656196
McGinnis KA, Justice AC, Kraemer KL, Saitz R, Bryant KJ, Fiellin DA. Comparing alcohol screening measures among HIV-infected and -uninfected men. Alcohol Clin Exp Res. 2013;37(3):435–42.
doi: 10.1111/j.1530-0277.2012.01937.x
pubmed: 23050632
Silverberg MJ, Levine-Hall T, Hood N, Anderson AN, Alexeeff SE, Lam JO, et al. Health system-based unhealthy alcohol use screening and treatment comparing demographically matched participants with and without HIV. Alcohol Clin Exp Res. 2020;44(12):2545–54.
doi: 10.1111/acer.14481
pubmed: 33067802
pmcid: 7725961
Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J, et al. The development of a standardized neighborhood deprivation index. J Urban Health. 2006;83(6):1041–62.
doi: 10.1007/s11524-006-9094-x
pubmed: 17031568
pmcid: 3261293
Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702–6.
doi: 10.1093/aje/kwh090
pubmed: 15033648
Dawson DA, Goldstein RB, Saha TD, Grant BF. Changes in alcohol consumption: United States, 2001–2002 to 2012–2013. Drug Alcohol Depend. 2015;148:56–61.
doi: 10.1016/j.drugalcdep.2014.12.016
pubmed: 25620731
Sterling SA, Palzes VA, Lu Y, Kline-Simon AH, Parthasarathy S, Ross T, et al. Associations between medical conditions and alcohol consumption levels in an adult primary care population. JAMA Netw Open. 2020;3(5): e204687.
doi: 10.1001/jamanetworkopen.2020.4687
pubmed: 32401315
pmcid: 7221504
Marshall BD, Operario D, Bryant KJ, Cook RL, Edelman EJ, Gaither JR, et al. Drinking trajectories among HIV-infected men who have sex with men: a cohort study of United States veterans. Drug Alcohol Depend. 2015;148:69–76.
doi: 10.1016/j.drugalcdep.2014.12.023
pubmed: 25596785
Palzes VA, Kline-Simon AH, Satre DD, Sterling S, Weisner C, Chi FW. Predictors of early and sustained cessation of heavy drinking over 5 years among adult primary care patients. Addiction. 2022;117(1):82–95.
doi: 10.1111/add.15612
pubmed: 34159681
Elliott JC, Stohl M, Aharonovich E, O’Leary A, Hasin DS. Reasons for drinking as predictors of alcohol involvement one year later among HIV-infected individuals with and without hepatitis C. Ann Med. 2016;48(8):634–40.
doi: 10.1080/07853890.2016.1206668
pubmed: 27460482
Williams EC, Hahn JA, Saitz R, Bryant K, Lira MC, Samet JH. Alcohol use and human immunodeficiency virus (HIV) infection: current knowledge, implications, and future directions. Alcohol Clin Exp Res. 2016;40(10):2056–72.
doi: 10.1111/acer.13204
pubmed: 27696523
pmcid: 5119641
Fillmore KM, Stockwell T, Chikritzhs T, Bostrom A, Kerr W. Moderate alcohol use and reduced mortality risk: systematic error in prospective studies and new hypotheses. Ann Epidemiol. 2007;17(5 Suppl):S16-23.
doi: 10.1016/j.annepidem.2007.01.005
pubmed: 17478320
Satre DD, Gordon NP, Weisner C. Alcohol consumption, medical conditions, and health behavior in older adults. Am J Health Behav. 2007;31(3):238–48.
doi: 10.5993/AJHB.31.3.2
pubmed: 17402864
pmcid: 3659165
Sullivan PS, Woodyatt C, Koski C, Pembleton E, McGuinness P, Taussig J, et al. A data visualization and dissemination resource to support HIV prevention and care at the local level: analysis and uses of the AIDSVu public data resource. J Med Internet Res. 2020;22(10): e23173.
doi: 10.2196/23173
pubmed: 33095177
pmcid: 7654504
Lee JS, Humes E, Hogan BC, Justice AC, Klein M, Gebo K, et al. Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004–18: a cohort study. Lancet HIV. 2022;9(Suppl 1):S2.
doi: 10.1016/S2352-3018(22)00067-4
pubmed: 35304844
California Department of Public Health. Behavioral and clinical characteristics of people living with diagnosed HIV in California, 2019. 2022. Available from: https://www.cdph.ca.gov/Programs/CID/DOA/CDPH%20Document%20Library/MMP_Report_2019_ADA.pdf .
Althoff KN, Buchacz K, Hall HI, Zhang J, Hanna DB, Rebeiro P, et al. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008. Ann Intern Med. 2012;157(5):325–35.
doi: 10.7326/0003-4819-157-5-201209040-00005
pubmed: 22944874
pmcid: 3534765
Nance RM, Delaney JAC, Simoni JM, Wilson IB, Mayer KH, Whitney BM, et al. HIV viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study. Ann Intern Med. 2018;169(6):376–84.
doi: 10.7326/M17-2242
pubmed: 30140916
pmcid: 6388406
O’Connor EA, Perdue LA, Senger CA, Rushkin M, Patnode CD, Bean SI, et al. Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018;320(18):1910–28.
doi: 10.1001/jama.2018.12086
pubmed: 30422198
Hasin DS, Aharonovich E, O’Leary A, Greenstein E, Pavlicova M, Arunajadai S, et al. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013;108(7):1230–40.
doi: 10.1111/add.12127
pubmed: 23432593
pmcid: 3755729